After a slow start to the month, the IPO market revved back to life with 13 IPOs coming to market this past week. SPAC activity picked up, with seven blank check IPOs raising $940 million. New filers continued to flood the IPO pipeline, with fourteen IPOs and nine SPACs submitting initial filings. Italian drug container supplier Stevanato Group (STVN)...read more
Sight Sciences, which provides medical and surgical devices for underserved eye diseases, raised $240 million by offering 10 million shares at $24, the high end of the upwardly revised range of $23 to $24. The company had originally filed to raise $150 million by offering 7 million shares at a range of $20 to $23, before upping the proposed share offering and range early on...read more
Sight Sciences, which provides medical and surgical devices for underserved eye diseases, raised the proposed deal size for its upcoming IPO on Wednesday. The Menlo Park, CA-based company now plans to raise $235 million by offering 10 million shares at a price range of $23 to $24. The company had previously filed to offer 7 million shares at a range of $20 to $23. At the midpoint...read more
Updated Monday, 7/12. After a slow holiday week, 15 IPOs are scheduled to raise nearly $4 billion in the week ahead. A handful of SPACs should also price. Italian drug container supplier Stevanato Group (STVN) plans to raise $900 million at a $6.8 billion market cap. Controlled by its founding family, the profitable company supplies glass vials,...read more
US IPO Weekly Recap: The summer IPO market heats up in a 13 IPO week
After a slow start to the month, the IPO market revved back to life with 13 IPOs coming to market this past week. SPAC activity picked up, with seven blank check IPOs raising $940 million. New filers continued to flood the IPO pipeline, with fourteen IPOs and nine SPACs submitting initial filings. Italian drug container supplier Stevanato Group (STVN)...read more
Sights set on stock market: Medical device maker Sight Sciences prices upsized IPO at $24 high end
Sight Sciences, which provides medical and surgical devices for underserved eye diseases, raised $240 million by offering 10 million shares at $24, the high end of the upwardly revised range of $23 to $24. The company had originally filed to raise $150 million by offering 7 million shares at a range of $20 to $23, before upping the proposed share offering and range early on...read more
Ocular medical device company Sight Sciences ups deal size by 57% ahead of $235 million IPO
Sight Sciences, which provides medical and surgical devices for underserved eye diseases, raised the proposed deal size for its upcoming IPO on Wednesday. The Menlo Park, CA-based company now plans to raise $235 million by offering 10 million shares at a price range of $23 to $24. The company had previously filed to offer 7 million shares at a range of $20 to $23. At the midpoint...read more
US IPO Week Ahead: Real estate, post-pandemic plays and more in a 15 IPO week
Updated Monday, 7/12. After a slow holiday week, 15 IPOs are scheduled to raise nearly $4 billion in the week ahead. A handful of SPACs should also price. Italian drug container supplier Stevanato Group (STVN) plans to raise $900 million at a $6.8 billion market cap. Controlled by its founding family, the profitable company supplies glass vials,...read more